Processa Pharmaceuticals Inc
(PCSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 12,051 | 11,457 | 20,257 | 12,134 | 15,137 |
| Operating Income | -12,051 | -11,457 | -20,257 | -12,134 | -15,137 |
| Interest Expense | 0 | 0 | 0 | 0 | 281 |
| Other Income | 201 | 336 | -7,167 | 175 | 3 |
| Pre-tax Income | -11,850 | -11,122 | -27,424 | -11,958 | -15,415 |
| Income Tax | N/A | N/A | N/A | -531 | -1,001 |
| Net Income Continuous | -11,850 | -11,122 | -27,424 | -11,428 | -14,414 |
| Net Income | $-11,850 | $-11,122 | $-27,424 | $-11,428 | $-14,414 |
| EPS Basic Total Ops | -96.75 | -212.00 | -851.25 | -375.00 | -1,270.00 |
| EPS Basic Continuous Ops | -96.82 | -211.99 | -851.18 | -372.99 | -960.92 |
| EPS Diluted Total Ops | -96.75 | -212.00 | -851.25 | -375.00 | -1,270.00 |
| EPS Diluted Continuous Ops | -96.82 | -211.99 | -851.18 | -372.99 | -960.92 |
| EPS Diluted Before Non-Recurring Items | -96.75 | -212.00 | -625.00 | -375.00 | -690.00 |
| EBITDA(a) | $-12,050 | $-11,457 | $-19,353 | $-11,343 | $-14,333 |